Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation
NCT00309270
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplant
Interventions
DRUG:
Campath-1H
Sponsor
Mario Negri Institute for Pharmacological Research